{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:06:26Z","timestamp":1778767586833,"version":"3.51.4"},"reference-count":31,"publisher":"Journal of Biomedical Research","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Res"],"published-print":{"date-parts":[[2025]]},"DOI":"10.7555\/jbr.39.20250074","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T03:55:22Z","timestamp":1747626922000},"page":"622","source":"Crossref","is-referenced-by-count":2,"title":["Homoharringtonine exerts anti-silicosis effects by inhibiting the CCR1 and PI3K\/AKT signaling pathways in lung fibroblasts"],"prefix":"10.7555","volume":"39","author":[{"given":"Xinying","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiyue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxiu","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhui","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4380","reference":[{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.1","doi-asserted-by":"publisher","unstructured":"Hoy RF, Dimitriadis C, Abramson M, et al. Prevalence and risk factors for silicosis among a large cohort of stone benchtop industry workers[J]. <i>Occup Environ Med<\/i>, 2023, 80(8): 439\u2013446.","DOI":"10.1136\/oemed-2023-108892"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.2","doi-asserted-by":"publisher","unstructured":"Blanco-P\u00e9rez J, Salgado-Barreira \u00c1, Blanco-Dorado S, et al. Clinical usefulness of serum angiotensin converting enzyme in silicosis[J]. <i>Pulmonology<\/i>, 2024, 30(4): 370\u2013377.","DOI":"10.1016\/j.pulmoe.2022.06.002"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.3","doi-asserted-by":"publisher","unstructured":"He R, Yuan X, Lv X, et al. Caveolin-1 negatively regulates inflammation and fibrosis in silicosis[J]. <i>J Cell Mol Med<\/i>, 2022, 26(1): 99\u2013107.","DOI":"10.1111\/jcmm.17045"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.4","doi-asserted-by":"publisher","unstructured":"Tan S, Chen S. Macrophage autophagy and silicosis: Current perspective and latest insights[J]. <i>Int J Mol Sci<\/i>, 2021, 22(1): 453.","DOI":"10.3390\/ijms22010453"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.5","doi-asserted-by":"publisher","unstructured":"Yang F, Hou R, Liu X, et al. Yangqing Chenfei formula attenuates silica-induced pulmonary fibrosis by suppressing activation of fibroblast <i>via<\/i> regulating PI3K\/AKT, JAK\/STAT, and Wnt signaling pathway[J]. <i>Phytomedicine<\/i>, 2023, 110: 154622.","DOI":"10.1016\/j.phymed.2022.154622"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.6","doi-asserted-by":"publisher","unstructured":"Li S, Li C, Zhang Y, et al. Targeting mechanics-induced fibroblast activation through CD44-RhoA-YAP pathway ameliorates crystalline silica-induced silicosis[J]. <i>Theranostics<\/i>, 2019, 9(17): 4993\u20135008.","DOI":"10.7150\/thno.35665"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.7","doi-asserted-by":"publisher","unstructured":"Wang M, Zhang Z, Liu J, et al. Gefitinib and fostamatinib target EGFR and SYK to attenuate silicosis: A multi-omics study with drug exploration[J]. <i>Signal Transduct Target Ther<\/i>, 2022, 7(1): 157.","DOI":"10.1038\/s41392-022-00959-3"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.8","doi-asserted-by":"publisher","unstructured":"Ahangari F, Becker C, Foster DG, et al. Saracatinib, a selective Src kinase inhibitor, blocks fibrotic responses in preclinical models of pulmonary fibrosis[J]. <i>Am J Respir Crit Care Med<\/i>, 2022, 206(12): 1463\u20131479.","DOI":"10.1164\/rccm.202010-3832OC"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.9","doi-asserted-by":"publisher","unstructured":"Takahashi T, Terada Y, Pasque MK, et al. Clinical features and outcomes of combined pulmonary fibrosis and emphysema after lung transplantation[J]. <i>Chest<\/i>, 2021, 160(5): 1743\u20131750.","DOI":"10.1016\/j.chest.2021.06.036"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.10","doi-asserted-by":"publisher","unstructured":"Pang J, Qi X, Luo Y, et al. Multi-omics study of silicosis reveals the potential therapeutic targets PGD<sub>2<\/sub> and TXA<sub>2<\/sub>[J]. <i>Theranostics<\/i>, 2021, 11(5): 2381\u20132394.","DOI":"10.7150\/thno.47627"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.11","doi-asserted-by":"publisher","unstructured":"Hao Y, Li J, Dan L, et al. Chinese medicine as a therapeutic option for pulmonary fibrosis: Clinical efficacies and underlying mechanisms[J]. <i>J Ethnopharmacol<\/i>, 2024, 318: 116836.","DOI":"10.1016\/j.jep.2023.116836"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.12","doi-asserted-by":"publisher","unstructured":"Kou N, Chen YB, Li XW, et al. Pulmonary administration of tetrandrine loaded Zinc-Alginate nanogels attenuates pulmonary fibrosis in rats[J]. <i>Int J Pharm<\/i>, 2024, 649: 123625.","DOI":"10.1016\/j.ijpharm.2023.123625"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.13","doi-asserted-by":"publisher","unstructured":"Gao J, Li C, Wang X, et al. Oridonin attenuates lung inflammation and fibrosis in silicosis <i>via<\/i> covalent targeting iNOS[J]. <i>Biomed Pharmacother<\/i>, 2022, 153: 113532.","DOI":"10.1016\/j.biopha.2022.113532"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.14","doi-asserted-by":"publisher","unstructured":"Li J, Gao J, Liu A, et al. Homoharringtonine-based induction regimen improved the remission rate and survival rate in Chinese childhood AML: A report from the CCLG-AML 2015 protocol study[J]. <i>J Clin Oncol<\/i>, 2023, 41(31): 4881\u20134892.","DOI":"10.1200\/JCO.22.02836"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.15","doi-asserted-by":"publisher","unstructured":"Kreutzer FP, Meinecke A, Mitzka S, et al. Development and characterization of anti-fibrotic natural compound similars with improved effectivity[J]. <i>Basic Res Cardiol<\/i>, 2022, 117(1): 9.","DOI":"10.1007\/s00395-022-00919-6"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.16","doi-asserted-by":"publisher","unstructured":"Mill CP, Fiskus WC, DiNardo CD, et al. Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM)[J]. <i>Blood Cancer J<\/i>, 2024, 14(1): 25.","DOI":"10.1038\/s41408-024-00981-4"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.17","doi-asserted-by":"publisher","unstructured":"Plett R, Mellor P, Kendall S, et al. Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel[J]. <i>Sci Rep<\/i>, 2022, 12(1): 15663.","DOI":"10.1038\/s41598-022-19621-7"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.18","doi-asserted-by":"publisher","unstructured":"Yang C, Zhang H, Chen M, et al. A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer[J]. <i>Elife<\/i>, 2022, 11: e71880.","DOI":"10.7554\/eLife.71880"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.19","doi-asserted-by":"publisher","unstructured":"Guo S, Bai X, Shi S, et al. TMEM16A, a homoharringtonine receptor, as a potential endogenic target for lung cancer treatment[J]. <i>Int J Mol Sci<\/i>, 2021, 22(20): 10930.","DOI":"10.3390\/ijms222010930"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.20","doi-asserted-by":"publisher","unstructured":"Cheng D, Lian W, Wang T, et al. The interplay of Cxcl10<sup>+<\/sup>\/Mmp14<sup>+<\/sup> monocytes and Ccl3<sup>+<\/sup> neutrophils proactively mediates silica-induced pulmonary fibrosis[J]. <i>J Hazard Mater<\/i>, 2024, 467: 133713.","DOI":"10.1016\/j.jhazmat.2024.133713"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.21","doi-asserted-by":"publisher","unstructured":"Ishida Y, Kimura A, Kondo T, et al. Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration[J]. <i>Am J Pathol<\/i>, 2007, 170(3): 843\u2013854.","DOI":"10.2353\/ajpath.2007.051213"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.22","doi-asserted-by":"publisher","unstructured":"Elsner J, Dulkys Y, Gupta S, et al. Differential pattern of CCR1 internalization in human eosinophils: Prolonged internalization by CCL5 in contrast to CCL3[J]. <i>Allergy<\/i>, 2005, 60(11): 1386\u20131393.","DOI":"10.1111\/j.1398-9995.2005.00893.x"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.23","doi-asserted-by":"publisher","unstructured":"Wu Z, Zhuang H, Yu Q, et al. Homoharringtonine combined with the heat shock protein 90 inhibitor IPI504 in the treatment of <i>FLT3<\/i>-ITD acute myeloid leukemia[J]. <i>Transl Oncol<\/i>, 2019, 12(6): 801\u2013809.","DOI":"10.1016\/j.tranon.2019.02.016"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.24","doi-asserted-by":"publisher","unstructured":"Khatua S, Nandi S, Nag A, et al. Homoharringtonine: Updated insights into its efficacy in hematological malignancies, diverse cancers and other biomedical applications[J]. <i>Eur J Med Res<\/i>, 2024, 29(1): 269.","DOI":"10.1186\/s40001-024-01856-x"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.25","doi-asserted-by":"publisher","unstructured":"Sun Y, Dai J, Jiao R, et al. Homoharringtonine inhibits fibroblasts proliferation, extracellular matrix production and reduces surgery-induced knee arthrofibrosis <i>via<\/i> PI3K\/AKT\/mTOR pathway-mediated apoptosis[J]. <i>J Orthop Surg Res<\/i>, 2021, 16(1): 9.","DOI":"10.1186\/s13018-020-02150-2"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.26","doi-asserted-by":"crossref","unstructured":"Liu SS, Liu C, Lv XX, et al. The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis[J]. <i>Immunity<\/i>, 2021, 54(9): 2042\u20132056.e8.","DOI":"10.1016\/j.immuni.2021.06.008"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.27","doi-asserted-by":"publisher","unstructured":"Shen J, Feng J, Wu Z, et al. Apelin prevents and alleviates crystalline silica-induced pulmonary fibrosis <i>via<\/i> inhibiting transforming growth factor beta 1-triggered fibroblast activation[J]. <i>Int J Biol Sci<\/i>, 2023, 19(13): 4004\u20134019.","DOI":"10.7150\/ijbs.81436"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.28","doi-asserted-by":"publisher","unstructured":"Imani J, Bodine SPM, Lamattina AM, et al. Dysregulated myosin in Hermansky-Pudlak syndrome lung fibroblasts is associated with increased cell motility[J]. <i>Respir Res<\/i>, 2022, 23(1): 167.","DOI":"10.1186\/s12931-022-02083-w"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.29","doi-asserted-by":"crossref","unstructured":"Qi J, Wu Y, Guo Z, et al. Fibroblast growth factor 21 alleviates idiopathic pulmonary fibrosis by inhibiting PI3K-AKT-mTOR signaling and stimulating autophagy[J]. <i>Int J Biol Macromol<\/i>, 2024, 273(Pt 1): 132896.","DOI":"10.1016\/j.ijbiomac.2024.132896"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.30","doi-asserted-by":"publisher","unstructured":"Park HS, Song JW, Park JH, et al. TXNIP\/VDUP1 attenuates steatohepatitis <i>via<\/i> autophagy and fatty acid oxidation[J]. <i>Autophagy<\/i>, 2021, 17(9): 2549\u20132564.","DOI":"10.1080\/15548627.2020.1834711"},{"key":"10.7555\/JBR.39.20250074.swyxyjzzywb.31","doi-asserted-by":"publisher","unstructured":"Yang X, Walton W, Cook DN, et al. The chemokine, CCL3, and its receptor, CCR1, mediate thoracic radiation-induced pulmonary fibrosis[J]. <i>Am J Respir Cell Mol Biol<\/i>, 2011, 45(1): 127\u2013135.","DOI":"10.1165\/rcmb.2010-0265OC"}],"container-title":["Journal of Biomedical Research"],"original-title":[],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T05:36:06Z","timestamp":1764826566000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.39.20250074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"alternative-id":["JBR-2025-0074"],"URL":"https:\/\/doi.org\/10.7555\/jbr.39.20250074","relation":{},"ISSN":["1674-8301","1674-8301"],"issn-type":[{"value":"1674-8301","type":"print"},{"value":"1674-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}